Refractory Lymphomas Active Not Recruiting Phase 1 Trials for Pevonedistat (DB11759)

Also known as: Refractory Lymphoma

IndicationStatusPhase
DBCOND0042145 (Refractory Lymphomas)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03323034Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomaTreatment